Healthcare Nov 20, 2020 10:25 AM (GMT+8) · EqualOcean
Qiming venture capital investment enterprise Deqi Pharmaceutical Co., Ltd. landed on the main board of Hong Kong Stock Exchange today. The offering price of deqi pharmaceutical was HK $18.08 per share, up 8.41% from HK $19.6 at the opening, with a market value of HK $13.097 billion. The public offering part of deqi Pharmaceutical Co., Ltd. has been oversubscribed 264 times. Deqi pharmaceutical is the 11th listed enterprise of Qiming venture capital in the year. Since August 2017, Qiming venture capital, as the leading investor, invested in the round a financing of deqi pharmaceutical, and then participated in the subsequent round of investment. Deqi pharmaceutical is a leading biopharmaceutical company focusing on innovative anti-tumor drugs